Zdrowie i gospodarka · 26.03.2009
Developing a Consolidated Pediatric Rheumatology Observational Registry; Public Workshop
The Food and Drug Administration (FDA) is announcing a public workshop entitled "Developing a Consolidated Pediatric Rheumatology Observational Registry." This 2-day public workshop is intended to seek constructive input from key stakeholders in the pediatric rheumatology community, the pharmaceutical industry and the public to explore the value and feasibility of developing a consolidated pediatric rheumatology observational registry.